Literature DB >> 3178724

5-Fluoromethylornithine, an irreversible and specific inhibitor of L-ornithine:2-oxo-acid aminotransferase.

G Daune1, F Gerhart, N Seiler.   

Abstract

5-Fluoromethylornithine (5-FMOrn) is the first specific irreversible inhibitor of L-ornithine:2-oxoacid aminotransferase (OAT) found. Single doses (greater than 10 mg/kg) of this compound inactivate OAT to a residual OAT-like activity. This activity (10-20% of total activity) is resistant to further inactivation by higher or repeated doses of 5-FMOrn, or incubation with the inactivator in vitro. Ornithine concentrations are greatly enhanced in various tissues, and urinary ornithine is dramatically increased, but no other amino acid is affected after acute treatment with 5-FMOrn. Repeated administration decreases carnosine and homocarnosine concentrations in brain. Toxic effects were not observed. The new inactivator is considered as a tool in the establishment of functions of OAT under physiological and pathological conditions.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3178724      PMCID: PMC1149323          DOI: 10.1042/bj2530481

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  34 in total

1.  PURIFICATION AND PROPERTIES OF RAT LIVER ORNITHINE DELTA-TRANSAMINASE.

Authors:  H J STRECKER
Journal:  J Biol Chem       Date:  1965-03       Impact factor: 5.157

2.  Esters of methanesulfonic acid as irreversible inhibitors of acetylcholinesterase.

Authors:  R KITZ; I B WILSON
Journal:  J Biol Chem       Date:  1962-10       Impact factor: 5.157

3.  Enzymatic synthesis and purification of L-pyrroline-5-carboxylic acid.

Authors:  R J Smith; S J Downing; J M Phang
Journal:  Anal Biochem       Date:  1977-09       Impact factor: 3.365

4.  Inhibition of pyridoxal enzymes by L-canaline.

Authors:  E L Rahiala; M Kekomäki; J Jänne; A Raina; N C Räihä
Journal:  Biochim Biophys Acta       Date:  1971-02-10

5.  Regulatory interrelations between GABA and polyamines. I. Brain GABA levels and polyamine metabolism.

Authors:  N Seiler; G Bink; J Grove
Journal:  Neurochem Res       Date:  1979-08       Impact factor: 3.996

6.  Limited blood-brain barrier transport of polyamines.

Authors:  W W Shin; W F Fong; S F Pang; P C Wong
Journal:  J Neurochem       Date:  1985-04       Impact factor: 5.372

7.  gamma-Vinyl GABA (4-amino-hex-5-enoic acid), a new selective irreversible inhibitor of GABA-T: effects on brain GABA metabolism in mice.

Authors:  M J Jung; B Lippert; B W Metcalf; P Böhlen; P J Schechter
Journal:  J Neurochem       Date:  1977-11       Impact factor: 5.372

8.  omega-Fluoromethyl analogues of omega-amino acids as irreversible inhibitors of 4-aminobutyrate:2-oxoglutarate aminotransferase.

Authors:  P Bey; M J Jung; F Gerhart; D Schirlin; V Van Dorsselaer; P Casara
Journal:  J Neurochem       Date:  1981-11       Impact factor: 5.372

9.  Developmental changes in mouse brain polyamine metabolism.

Authors:  S I Laitinen; P H Laitinen; O A Hietala; A E Pajunen; R S Piha
Journal:  Neurochem Res       Date:  1982-12       Impact factor: 3.996

10.  An investigation of the properties of ornithine aminotransferase after inactivation by the 'suicide' inhibitor aminohexynoate and use of the compound as a probe of intracellullar protein turnover.

Authors:  E D Jones; J M Basford; R A John
Journal:  Biochem J       Date:  1983-01-01       Impact factor: 3.857

View more
  15 in total

Review 1.  Ornithine aminotransferase versus GABA aminotransferase: implications for the design of new anticancer drugs.

Authors:  Hyunbeom Lee; Jose I Juncosa; Richard B Silverman
Journal:  Med Res Rev       Date:  2014-08-22       Impact factor: 12.944

2.  Phenelzine causes an increase in brain ornithine that is prevented by prior monoamine oxidase inhibition.

Authors:  Erin M MacKenzie; Suzanne L Grant; Glen B Baker; Paul L Wood
Journal:  Neurochem Res       Date:  2007-08-31       Impact factor: 3.996

3.  Decreased hyperammonaemia and orotic aciduria due to inactivation of ornithine aminotransferase in mice with a hereditary abnormal ornithine carbamoyltransferase.

Authors:  N Seiler; C Grauffel; G Daune-Anglard; S Sarhan; B Knödgen
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

4.  Transgenic mice over-producing putrescine in their tissues do not convert the diamine into higher polyamines.

Authors:  M Halmekytö; L Alhonen; L Alakuijala; J Jänne
Journal:  Biochem J       Date:  1993-04-15       Impact factor: 3.857

5.  (4S)-4-amino-5,6-heptadienoic acid (MDL 72483): a potent anticonvulsant GABA-T inhibitor.

Authors:  S Sarhan; P Casara; B Knödgen; N Seiler
Journal:  Neurochem Res       Date:  1991-03       Impact factor: 3.996

Review 6.  Endogenous ornithine in search for CNS functions and therapeutic applications.

Authors:  N Seiler; G Daune-Anglard
Journal:  Metab Brain Dis       Date:  1993-09       Impact factor: 3.584

7.  Protection against lethal ammonia intoxication: synergism between endogenous ornithine and L-carnitine.

Authors:  S Sarhan; B Knoedgen; N Seiler
Journal:  Metab Brain Dis       Date:  1994-03       Impact factor: 3.584

8.  Effects of inhibition of ornithine aminotransferase on thioacetamide-induced hepatogenic encephalopathy.

Authors:  S Sarhan; B Knödgen; C Grauffel; N Seiler
Journal:  Neurochem Res       Date:  1993-04       Impact factor: 3.996

9.  Effects of ornithine aminotransferase inactivation by 5-fluoromethylornithine in rats following portacaval anastomosis.

Authors:  G Therrien; S Sarhan; B Knödgen; R F Butterworth; N Seiler
Journal:  Metab Brain Dis       Date:  1994-09       Impact factor: 3.584

10.  DL-canaline and 5-fluoromethylornithine. Comparison of two inactivators of ornithine aminotransferase.

Authors:  F N Bolkenius; B Knödgen; N Seiler
Journal:  Biochem J       Date:  1990-06-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.